48North Signs Extraction Partnership and Outdoor Supply Agreement with humble+fume

TORONTO, April 11, 2019 /CNW/ - 48North Cannabis Corp. ("48North" or the "Company") (TSXV:NRTH) is pleased to announce that it has entered into a formal partnership with humble+fume.

Under the extraction partnership, humble+fume will build a state-of-the-art cannabis extraction facility and packaging line within 48North's fully-licensed cultivation and processing facility ("Good House") in Brantford, Ontario. This announcement represents a key milestone in the execution of the Company's extraction strategy. Upon completion of the extraction facility, 48North will be able to process over 30,000 kg of cannabis mass annually. The extraction equipment and packaging line will be a shared resource between humble+fume and 48North.

The build-out of the extraction facility and packaging line is expected to be completed in summer 2019 and is being paid by humble+fume.

As a result, 48North's Good House will be fully-equipped to both manufacture and conduct C02 extraction, producing full-spectrum oil, distillates and isolates, all critical ingredients in the development of next-generation, value-added cannabis products, which will be available for retail sale by 48North in October 2019.

48North will be using this equipment to execute on its previously announced licensing agreements with Mother + Clone and Avitas in the manufacturing of their 100% natural additive free, single strain, ultra-refined and purified products.

In addition to the extraction agreement, 48North is also pleased to announce that humble+fume has agreed to purchase 5,000 kg of dried cannabis and 1,000 kg of trim, from its outdoor cultivation site the Good Farm at fair-market value, pending Health Canada approval.

Pending Health Canada approval, 48North will be one of the first Licensed Producers in Canada to have an outdoor cannabis farm ("Good Farm") expected to produce over 40,000 KG of dried cannabis, from over 3.7 million sq. ft. of cultivation space, at a low-cost. 48North expects to plant and harvest cannabis outdoors at its Good Farm in 2019. 

"48North plans on using a significant portion of its significant outdoor production volume for extracted, value-added products. The build-out of the extraction facility and packaging line at the Good House, guarantees 48North's ability to extract and process its sun-grown organic cannabis for next-generation cannabis products," said Alison Gordon co-CEO of 48North.

"humble+fume was the right partner for us. Not only are they fully funding the build-out of 48North's extraction facility, but in addition, they bring to the table a robust distribution network, R&D expertise, and a management team with significant experience in having designed and operated three large-scale extraction facilities both in the United States and in Canada."

About 48North

48North Cannabis Corp. (TSXV: NRTH) is a vertically integrated cannabis company focused on the health and wellness market through cultivation and extraction, as well as the creation of innovative, authentic brands for next-generation cannabis products. 48North is developing formulations and manufacturing capabilities for its own proprietary products, as well as positioning itself to contract manufacture similar products for third parties. 48North operates two indoor-licensed cannabis production sites in Ontario with more than 86,000 square feet of production capacity. 48North cultivates unique genetics at its wholly owned subsidiaries, DelShen Therapeutics Corp. ("DelShen") and 2599760 Ontario Corp. dba Good & Green ("Good & Green"), both Licensed Producers under the Cannabis Act. In addition, subject to Health Canada approval, 48North expects to operate a 100-acre organic farm providing 48North with organic, sun-grown cannabis securing a significant first-mover advantage in the production of low-cost, next-generation, extract-based cannabis products. 48North has a growing portfolio of brands that include Latitude, a women's cannabis platform (explorelatitude.com), Mother & Clone, a rapid-acting sublingual cannabis nanospray (momandclone.com) and Avitas, a single strain vaporizer cartridge (avitasgrown.com).

DISCLAIMER & READER ADVISORY

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release. Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could," "intend," "expect," "believe," "will," "projected," "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. Forward-looking statements in this news release include statements relating to the business plan and future operations of the Company, including its application with Health Canada for a cultivation licence for its 100-acre outdoor grow property. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including the possibility that the business plan described herein will not be completed, that 48North may not derive the expected benefits from such business plans, or that applicable regulatory approvals will be obtained to carry out the activities contemplated herein. The business of the Company is subject to a number of material risks and uncertainties. Please refer to the Company's SEDAR filings for further details. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the Company being able to obtain the necessary corporate, regulatory and other third-party approvals, and licensing and other risks associated with the Cannabis Act. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

SOURCE 48North Cannabis Co.

Alison Gordon, Chief Executive Officer, ([email protected]); Connor Whitworth, Director of Corporate Affairs, ([email protected])